search:

ONCOLOGY: Ovarian Cancer Trial - Karenitecin(R)-BNP1350

From: Hope Waltman (anonymous@obgyn.net)
Sat, 9 Feb 2008 10:17:45 -0600 (CST)


BioNumerik Commences Global Phase III Ovarian Cancer Trial On Novel Anticancer Drug Candidate Known As Karenitecin(R)

"BioNumerik Pharmaceuticals, Inc. announced treatment of the first patient in a global Phase III clinical trial of BioNumerik's anticancer drug candidate known as Karenitecin(R) in advanced ovarian cancer patients. BioNumerik is developing Karenitecin (also known as BNP1350) as an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs.

Four Phase II clinical trials of intravenously administered Karenitecin have been completed in the U.S. in patients with advanced ovarian cancer, metastatic malignant melanoma, advanced non-small cell lung cancer, and primary brain tumors."

http://www.medicalnewstoday.com/articles/96598.php

Regards, Hope Waltman, Fibroid Forum and WH Forum Moderator

http://www.hopeforfibroids.org http://www.doctorsinfoweb.com/doctors/whatsnew.htm http://www.obgyn.net/fibroid-resource-center/




recommended search...
Google
OBGYN.net forums endometriosis zone Web

use when must restrict search to only the women's health forum...
Enter search keywords:
Returns per screen: Require all keywords:
Return to [ Women's Health Forum ] Report TECHNICAL Problems ONLY to: webmaster@obgyn.net
Last Updated: Wed Dec 2 06:55:20 2009

Women's Insurance Checklist from Auto Insurance Quote

home | medical professionals | women | industry | forums | international
e-mail | about us | advertising | our sponsors | contact us | disclaimer |

This information is provided for educational purposes only.
Please read the disclaimer. ©1996-2008, all rights reserved.
Do not reproduce without permission of MediSpecialty.com